Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Statement [Abstract]
Collaboration revenue	$ 359	$ 14	$ 1,352	$ 14
Operating expenses:
Research and development	10,048	7,077	29,346	19,352
General and administrative	5,137	4,018	13,157	10,639
Total operating expenses	15,185	11,095	42,503	29,991
Loss from operations	(14,826)	(11,081)	(41,151)	(29,977)
Other income:
Interest income	60	26	108	81
Total other income	60	26	108	81
Net loss	(14,766)	(11,055)	(41,043)	(29,896)
Comprehensive loss	$ (14,766)	$ (11,055)	$ (41,043)	$ (29,896)
Net loss per share attributable to common stockholders- basic	$ (0.40)	$ (0.85)	$ (1.47)	$ (2.30)
Net loss per share attributable to common stockholders- diluted	$ (0.40)	$ (0.85)	$ (1.47)	$ (2.30)
Weighted-average common shares outstanding-basic	36,826,364	13,001,514	28,014,434	12,979,837
Weighted-average common shares outstanding-diluted	36,826,364	13,001,514	28,014,434	12,979,837